Security key
83006G401
60 Degrees Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SXTP)
CUSIP: 83006G401
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 4,285,676
- Total 13F shares
- 42,595
- Share change
- +27,354
- Total reported value
- $62,905
- Price per share
- $1.47
- Number of holders
- 7
- Value change
- +$40,482
- Number of buys
- 5
- Number of sells
- 1
Report period
Q3 2025
Institutions
7
Top holders
7
SXTP full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
60 DEGREES PHARMACEUTICALS, INC. SEC filings
60 DEGREES PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 83006G401
Recent filing periods:
Top shareholders of SXTP - 60 Degrees Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.
13D/G
3/4/5
13F
Evidence coverage
22 holder rows
Latest evidence as of 30 Sep 2025.
Highest disclosed value: $5,475,241.
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| CVI Investments, Inc. |
13D/G
|
9.9%
|
$670,061
455,545 shares
|
+$187,456 | 30 Sep 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$226,656
77,357 shares
|
$0 | 31 Mar 2025 |
| Orca Capital AG |
13D/G
|
4.9%
|
$382,327
166,229 shares
|
$0 | 15 Jul 2025 |
| Ayrton Capital LLC |
13D/G
|
4.1%
|
$260,977
177,427 shares
|
+$20,515 | 30 Sep 2025 |
| Cheryl Xu |
3/4/5
Director
|
0.37%
|
$45,866
15,816 shares
|
+$14,410 | 03 Jun 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.29%
|
$29,662
12,516 shares
|
— | 30 Jun 2025 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.06%
|
$6,157
2,598 shares
|
— | 30 Jun 2025 |
| OSAIC HOLDINGS, INC. |
13F
Company
|
0%
|
$237
100 shares
|
— | 30 Jun 2025 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
0%
|
$30
13 shares
|
— | 30 Jun 2025 |
| Knight Therapeutics Inc. |
3/4/5
Former 10% Owner
|
—
mixed-class rows
|
$5,475,241
1,232,700 shares
mixed-class rows
|
— | 28 Jul 2023 |
| KENTUCKY TECHNOLOGY INC. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$196,875
525,000 shares
|
— | 11 Jul 2023 |
| Florida State University Research Foundation Inc. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$151,875
405,000 shares
|
— | 11 Jul 2023 |
| Tyrone Miller |
3/4/5
CFO
|
—
mixed-class rows
|
$38,237
101,370 shares
mixed-class rows
|
— | 17 Jan 2025 |
| Walleye Capital LLC |
13F
Company
|
—
class O/S missing
|
$12,572
222,906 shares
|
— | 30 Jun 2025 |
| Kristen Landon |
3/4/5
Chief Operating Officer
|
—
mixed-class rows
|
$11,713
8,707 shares
mixed-class rows
|
— | 17 Jan 2025 |
| CLEAR STREET LLC |
13F
Company
|
—
class O/S missing
|
$8,234
145,987 shares
|
— | 30 Jun 2025 |
| Charles W. Allen |
3/4/5
Director
|
—
mixed-class rows
|
$4,622
18,000 shares
mixed-class rows
|
— | 31 Dec 2023 |
| Paul Field |
3/4/5
Director
|
—
mixed-class rows
|
$4,014
18,000 shares
mixed-class rows
|
— | 31 Dec 2023 |
| Stephen Toovey |
3/4/5
Director
|
—
mixed-class rows
|
$4,014
18,000 shares
mixed-class rows
|
— | 31 Dec 2023 |
| TORNO CAPITAL, LLC |
13F
Company
|
—
class O/S missing
|
$2,660
47,169 shares
|
— | 30 Jun 2025 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
class O/S missing
|
$783
17,668 shares
|
— | 30 Jun 2025 |
| UBS Group AG |
13F
Company
|
—
mixed-class rows
|
$95
1,515 shares
mixed-class rows
|
— | 30 Jun 2025 |
Institutional Holders of 60 Degrees Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SXTP) as of Q3 2025
As of 30 Sep 2025,
60 Degrees Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SXTP) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,595 shares.
The largest 7 holders included
DRW Securities, LLC, GEODE CAPITAL MANAGEMENT, LLC, Tower Research Capital LLC (TRC), UBS Group AG, CITIGROUP INC, OSAIC HOLDINGS, INC., and BANK OF AMERICA CORP /DE/.
This page lists
7
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
5
Q3 2025 holders
7
Holder diff
2
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.